Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic SclerosisJacob M. van Laar, A Tyndall, Dominique Farge et al.|JAMA|2014Cited by 739
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*Sophie Georgin‐Lavialle, Thomas Cluzeau, Achille Aouba et al.|British Journal of Dermatology|2021Cited by 414
Note of Republication: A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered QuestionnairesN. Costedoat‐Chalumeau, David Isenberg, Frédéric Houssiau et al.|Clinical Pharmacology & Therapeutics|2017Cited by 71
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 casesÈve Zakine, C. Deligny, Loula Papageorgiou et al.|Journal of the American Academy of Dermatology|2022Cited by 67
Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 AutoantibodiesAurore Abel, Étienne Rivière, Estibaliz Lazaro et al.|European Journal of Internal Medicine|2023Cited by 12